1. Home
  2. CLDX vs KLG Comparison

CLDX vs KLG Comparison

Compare CLDX & KLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • KLG
  • Stock Information
  • Founded
  • CLDX 1983
  • KLG 2022
  • Country
  • CLDX United States
  • KLG United States
  • Employees
  • CLDX N/A
  • KLG N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • KLG Packaged Foods
  • Sector
  • CLDX Health Care
  • KLG Consumer Staples
  • Exchange
  • CLDX Nasdaq
  • KLG Nasdaq
  • Market Cap
  • CLDX 1.8B
  • KLG 1.6B
  • IPO Year
  • CLDX 2008
  • KLG N/A
  • Fundamental
  • Price
  • CLDX $25.77
  • KLG $20.01
  • Analyst Decision
  • CLDX Buy
  • KLG Hold
  • Analyst Count
  • CLDX 8
  • KLG 8
  • Target Price
  • CLDX $64.83
  • KLG $18.88
  • AVG Volume (30 Days)
  • CLDX 992.8K
  • KLG 992.4K
  • Earning Date
  • CLDX 11-06-2024
  • KLG 02-11-2025
  • Dividend Yield
  • CLDX N/A
  • KLG 3.19%
  • EPS Growth
  • CLDX N/A
  • KLG N/A
  • EPS
  • CLDX N/A
  • KLG 0.78
  • Revenue
  • CLDX $9,976,000.00
  • KLG $2,719,000,000.00
  • Revenue This Year
  • CLDX N/A
  • KLG N/A
  • Revenue Next Year
  • CLDX N/A
  • KLG N/A
  • P/E Ratio
  • CLDX N/A
  • KLG $25.62
  • Revenue Growth
  • CLDX 128.55
  • KLG N/A
  • 52 Week Low
  • CLDX $22.93
  • KLG $11.97
  • 52 Week High
  • CLDX $53.18
  • KLG $24.63
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 45.64
  • KLG 52.94
  • Support Level
  • CLDX $24.48
  • KLG $20.20
  • Resistance Level
  • CLDX $26.66
  • KLG $21.12
  • Average True Range (ATR)
  • CLDX 1.19
  • KLG 0.63
  • MACD
  • CLDX 0.03
  • KLG -0.16
  • Stochastic Oscillator
  • CLDX 35.73
  • KLG 16.40

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About KLG WK Kellogg Co

WK Kellogg is the second-largest cereal manufacturer in North America. Its cereal brands include Special K, Frosted Flakes, Raisin Bran, Froot Loops, Frosted Mini-Wheats, Kashi, Corn Flakes, Rice Krispies, Apple Jacks, and Bear Naked. The company was spun off from the former Kellogg business, now known as Kellanova, where the former firm's global snacks portfolio and international cereal brands are now housed. WK Kellogg, which began trading independently in October 2023, generates the bulk of its sales (about 88% of its fiscal 2023 base) from the US.

Share on Social Networks: